A Phase 1, Open-label, Single-arm Study of APR 2020 in Transfusion Dependent, Steroid Resistant Pediatric and Adolescent Subjects With RPS19 Deficient Diamond Blackfan Anemia by Transplantation of Autologous CD34+ Stem Cells Transduced With CLIN LV EFS coRPS19 PRE* (APR-2020)
Latest Information Update: 17 May 2026
At a glance
- Drugs APR 2020 (Primary)
- Indications Diamond-Blackfan syndrome
- Focus Adverse reactions; Therapeutic Use
- Sponsors Apriligen
Most Recent Events
- 20 Apr 2026 Planned primary completion date changed from 1 Mar 2027 to 1 Apr 2027.
- 20 Apr 2026 Status changed from not yet recruiting to recruiting.
- 25 Mar 2026 New trial record